Abstract
Transplantation of allogeneic pancreatic islets for the treatment of patients with Type 1 diabetes mellitus (T1DM) is now a reality. The steady progress that has allowed for the recent successful clinical trials world-wide follows a steep learning curve and the perseverance of the international islet transplantation community. The Clinical Islet Transplant Program at the Diabetes Research Institute - University of Miami has contributed to the progress in the field with a 20-year track record. It has been a long journey and despite the intermediate success, more work is needed in order to achieve the ultimate goal of a safe and long-lasting treatment for patients with T1DM.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 177-204 |
| Number of pages | 28 |
| Journal | Clinical transplants |
| State | Published - 2004 |
ASJC Scopus subject areas
- Medicine(all)
Fingerprint Dive into the research topics of 'Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.'. Together they form a unique fingerprint.
Cite this
Pileggi, A., Ricordi, C., Kenyon, N. S., Froud, T., Baidal, D. A., Kahn, A., Selvaggi, G., & Alejandro, R. (2004). Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami. Clinical transplants, 177-204.